New York Hospital Queens acquired two additional practices in the borough this week, adding more primary care and specialty services to the hospital’s expanding network.
“NYHQ is committed to expanding access to primary care and providing easier access to specialty services. We are proud to bring these physicians on board to help protect and promote the health of our community,” said Stephen Mills, president and chief executive officer at NYHQ. “The hospital, through our physician group, New York Queens Medicine & Surgery P.C., continues to acquire and build additional practices throughout the borough.”
The practices the hospital gained were Bayside Primary Care, at 44-02 Francis Lewis Blvd., and Queens Diabetes and Endocrinology, at 59-45 161st St. in Flushing. Bayside Primary Care has primary care doctors and a cardiologist on staff. Queens Diabetes and Endocrinology offers treatment for patients suffering from a number of conditions, including diabetes and thyroid disease.
The hospital also announced it was adding 10 specialists to Whitestone Primary Care, at 14-02 150th St., and Maspeth Multispecialty Care, at 72-41 Grand Ave., practices which were already part of the hospital’s network.
Reach reporter Alex Robinson by e-mail at arobinson@
©2014 Community News Group
By submitting this comment, you agree to the following terms:
You agree that you, and not TimesLedger.com or its affiliates, are fully responsible for the content that you post. You agree not to post any abusive, obscene, vulgar, slanderous, hateful, threatening or sexually-oriented material or any material that may violate applicable law; doing so may lead to the removal of your post and to your being permanently banned from posting to the site. You grant to TimesLedger.com the royalty-free, irrevocable, perpetual and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part world-wide and to incorporate it in other works in any form, media or technology now known or later developed.